Financial support and resources available for businesses impacted by COVID-19.

Support for businesses impacted by COVID-19.

Interface Biologics Inc.

Interface Biologics is a privately held early commercial stage company that develops transformative biomedical polymer technology to improve the safety and effectiveness of medical devices.

Our partnership

Interface is a BDC Capital Healthcare Venture Fund company, co-managed in partnership by Amplitude Venture Capital.

Contact

Dion Madsen, Founding partner at Amplitude Venture Capital.

Investment year: 2005
Industry sector: Devices
Region: Ontario
Website